Effect of inactivation method on the cross-protective immunity induced by whole 'killed' influenza A viruses and commercial vaccine preparations

Journal of General Virology

Volumn 91, Issue 6, 2010, Pages 1450-1460

  Furuya, Yoichi ^a   Regner, Matthias ^a   Lobigs, Mario ^b   Koskinen, Aulikki ^a   Müllbacher, Arno ^a   Alsharifi, Mohammed ^a  

^a Biology and Environment   (Australia)

^b INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FLUVAX; FORMALDEHYDE; FORMALIN INACTIVATED INFLUENZA VACCINE; GAMMA IRRADIATED INFLUENZA VACCINE; INACTIVATED VIRUS VACCINE; INFLUENZA VACCINE; ULTRAVIOLET INACTIVATED VIRUS VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CROSS PROTECTION; CYTOTOXIC T LYMPHOCYTE; DRUG EFFECT; DRUG EFFICACY; FEMALE; FREEZE DRYING; GAMMA IRRADIATION; HEMAGGLUTINATION; IMMUNE RESPONSE; IMMUNOGENICITY; INFLUENZA; INFLUENZA A (H3N2); INFLUENZA VIRUS A H3N2; MOUSE; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; ULTRAVIOLET IRRADIATION; VACCINE PRODUCTION; VIRUS IMMUNITY; VIRUS INACTIVATION; VIRUS LOAD; VIRUS STRAIN;

ANIMALS; BODY WEIGHT; CROSS PROTECTION; FEMALE; FORMALDEHYDE; GAMMA RAYS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; LUNG; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; SURVIVAL ANALYSIS; T-LYMPHOCYTES, CYTOTOXIC; ULTRAVIOLET RAYS; VACCINES, INACTIVATED; VIRAL LOAD; VIRUS INACTIVATION;

AVES; INFLUENZA A VIRUS; MUS;

EID: 77952678672     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.018168-0     Document Type: Article

References (50)

1. Ada, G. L. & Jones, P. D. (1986). The immune response to influenza infection. Curr Top Microbiol Immunol 128, 1-54.
2. Alsharifi, M. & Müllbacher, A. (2010). The γ-irradiated influenza vaccine and the prospect of producing safe vaccines in general. Immunol Cell Biol 88, 103-104.
3. Alsharifi, M., Furuya, Y., Bowden, T. R., Lobigs, M., Koskinen, A., Regner, M., Trinidad, L., Boyle, D. B. & Müllbacher, A. (2009). Intranasal flu vaccine protective against seasonal and H5N1 avian influenza infections. PLoS One 4, e5336.
4. Andrew, S. M., Titus, J. A. & Zumstein, L. (2001). Dialysis and concentration of protein solutions. Curr Protoc Immunol Appendix 3, Appendix 3H.
5. Barry, D. W., Staton, E. & Mayner, R. E. (1974). Inactivated influenza vaccine efficacy: diminished antigenicity of split-product vaccines in mice. Infect Immun 10, 1329-1336.
6. Barry, D. W., Mayner, R. E., Staton, E., Dunlap, R. C., Rastogi, S. C., Hannah, J. E., Blackburn, R. J., Nortman, D. F. & Graze, P. R. (1976). Comparative trial of influenza vaccines. I. Immunogenicity of whole virus and split product vaccines in man. Am J Epidemiol 104, 34-46.
7. Blazevic, V., Trubey, C. M. & Shearer, G. M. (2000). Comparison of in vitro immunostimulatory potential of live and inactivated influenza viruses. Hum Immunol 61, 845-849.
8. Braciale, T. J. & Yap, K. L. (1978). Role of viral infectivity in the induction of influenza virus-specific cytotoxic T cells. J Exp Med 147, 1236-1252. (Pubitemid 8318089)
9. Budowsky, E. I., Bresler, S. E., Friedman, E. A. & Zheleznova, N. V. (1981). Principles of selective inactivation of viral genome. I. UV-induced inactivation of influenza virus. Arch Virol 68, 239-247.
10. Budowsky, E. I., Friedman, E. A., Zheleznova, N. V. & Noskov, F. S. (1991). Principles of selective inactivation of viral genome. VI. Inactivation of the infectivity of the influenza virus by the action of beta-propiolactone. Vaccine 9, 398-402.
11. Budowsky, E. I., Smirnov Yu, A. & Shenderovich, S. F. (1993). Principles of selective inactivation of viral genome. VIII. The influence of beta-propiolactone on immunogenic and protective activities of influenza virus. Vaccine 11, 343-348.
12. Chen, G. L., Lamirande, E. W., Jin, H., Kemble, G. & Subbarao, K. (2010). Safety, immunogencity, and efficacy of a cold-adapted A/Ann Arbor/6/60 (H2N2) vaccine in mice and ferrets. Virology 398, 109-114.
13. De Benedictis, P., Beato, M. S. & Capua, I. (2007). Inactivation of avian influenza viruses by chemical agents and physical conditions: a review. Zoonoses Public Health 54, 51-68. (Pubitemid 46376471)
14. De Flora, S. & Badolati, G. (1973a). Inactivation of A2-Hong Kong influenza virus by heat and by freeze-thawing. Comparison of untreated and gamma-irradiated preparations. Boll Ist Sieroter Milan 52, 293-305.
15. De Flora, S. & Badolati, G. (1973b). Thermal inactivation of untreated and gamma-irradiated A2-Aichi-2-68 influenza virus. J Gen Virol 20, 261-265.
16. Fridman, A. L., Ermolaev, A. I., Bichurina, M. A. & Chubarova, N. I. (1979 ). Effect of gamma radiation on the biological characteristics of purified influenza virus. Tr Inst Im Pastera 52, 135-139.
17. Goldstein, M. A. & Tauraso, N. M. (1970). Effect of formalin, beta-propiolactone, merthiolate, and ultraviolet light upon influenza virus infectivity chicken cell agglutination, hemagglutination, and antigenicity. Appl Microbiol 19, 290-294.
18. IAEA(1973). The Manual on Radiation Sterilization of Medical and Biological Material: the Technical Reports Series. 149, pp. 65-70. Vienna: International Atomic Energy Agency.
19. Ichinohe, T., Tamura, S., Kawaguchi, A., Ninomiya, A., Imai, M., Itamura, S., Odagiri, T., Tashiro, M., Takahashi, H. & other authors (2007). Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine. J Infect Dis 196, 1313-1320.
20. Jackson, V. (1978). Studies on histone organization in the nucleosome using formaldehyde as a reversible cross-linking agent. Cell 15, 945-954.
21. Kantorovich-Prokudina, E. N., Kaverin, N. V., Semenova, N. P., Miasnikova, I. A. & Berezina, O. N. (1978 ). Preventive effect of UV-inactivated defective interfering influenza virus in experimental infection. Vopr Virusol 6, 673-677 in Russian.
22. Knipe, D. M. & Howley, P. M. (2001). Fields Virology, vol. 1. Philadelphia (EUA): Lippincott Williams & Wilkins.
23. Kulevich, E. E. & Kosiakov, P. N. (1974). Immunogenic properties of A2/Hongkong/1/68 influenza virus inactivated with gamma rays. Vopr Virusol 6, 696-700 in Russian.
24. Lidbury, B. A., Grissell, T. V., Sizer, P. J., Pang, G. T., Clancy, R. & Cripps, A. W. (1997). Erythrocytes enhance the immunogenicity of oral vaccination with gamma irradiated influenza virus: increasing the dose of irradiation results in a significant diminution of lung IgA response. Vaccine 15, 1529-1537. (Pubitemid 27402135)
25. Lowy, R. J., Vavrina, G. A. & LaBarre, D. D. (2001). Comparison of gamma and neutron radiation inactivation of influenza A virus. Antiviral Res 52, 261-273.
26. Martinson, H. G., True, R., Lau, C. K. & Mehrabian, M. (1979). Histon - histone interactions within chromatin. Preliminary location of multiple contact sites between histones 2A, 2B, and 4. Biochemistry 18, 1075-1082.
27. Mazanec, M. B., Kaetzel, C. S., Lamm, M. E., Fletcher, D. & Nedrud, J. G. (1992). Intracellular neutralization of virus by immunoglobulin A antibodies. Proc Natl Acad Sci U S A 89, 6901-6905.
28. Mazanec, M. B., Coudret, C. L. & Fletcher, D. R. (1995a). Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies. J Virol 69, 1339-1343.
29. Mazanec, M. B., Kaetzel, C. S., Lamm, M. E., Fletcher, D., Peterra, J. & Nedrud, J. G. (1995b). Intracellular neutralization of Sendai and influenza viruses by IgA monoclonal antibodies. Adv Exp Med Biol 371A, 651-654.
30. Migunov, A. I., Aron, R. A., Sirotkin, A. K., Chernina, L. F. & Kuznetsov, O. K. (1986). Physicochemical characteristics of an influenza virus population inactivated by gamma rays. Radiobiologiia 26, 647-651.
31. Müllbacher, A., Ada, G. L. & Hla, R. T. (1988). Gamma-irradiated influenza A virus can prime for a cross-reactive and cross-protective immune response against influenza A viruses. Immunol Cell Biol 66, 153-157.
32. Müllbacher, A., Hill, A. B., Blanden, R. V., Cowden, W. B., King, N. J. & Hla, R. T. (1991). Alloreactive cytotoxic T cells recognize MHC class I antigen without peptide specificity. J Immunol 147, 1765-1772.
33. Müllbacher, A., Lobigs, M., Alsharifi, M. & Regner, M. (2006). Cytotoxic T-cell immunity as a target for influenza vaccines. Lancet Infect Dis 6, 255-256.
34. + cytotoxic T lymphocyte responses induced in mucosa-associated tissues. Virology 254, 50-60.
35. Noack, K., Tischner, H., Brauniger, S., Nordheim, W. & Pohl, W. D. (1986 ). Long-term effect of oral immunization against influenza with a gamma ray-inactivated vaccine in mice. Z Erkr Atmungsorgane 166, 286-289.
36. Ortbals, D. W. & Liebhaber, H. (1978). Comparison of immunogenicity of a whole virion and a subunit influenza vaccine in adults. J Clin Microbiol 8, 431-434.
37. Palese, P. (2006). Making better influenza virus vaccines? Emerg Infect Dis 12, 61-65.
38. Pang, G. T., Clancy, R. L., O'Reilly, S. E. & Cripps, A. W. (1992). A novel particulate influenza vaccine induces long-term and broad-based immunity in mice after oral immunization. J Virol 66, 1162-1170.
39. Plotkin, S. A., Orenstein, W. A. & Offit, P. A. (2008). Vaccines. Philadelphia: W. B. Saunders & Co.
40. Polianskaia, Nlu. (1979 ). Preparation of an influenza vaccine from allantoic viral cultures inactivated with UV irradiation. Tr Inst Im Pastera 52, 107-110 in Russian.
41. Quilligan, J. J., Jr, Francis, T., Jr & Minuse, E. (1949). Reactions to an influenza virus vaccine in infants and children. Am J Dis Child 78, 295-301.
42. Redfield, D. C., Richman, D. D., Oxman, M. N. & Kronenberg, L. H. (1981). Psoralen inactivation of influenza and herpes simplex viruses and of virus-infected cells. Infect Immun 32, 1216-1226. (Pubitemid 11109832)
43. Salk, J. E. (1948). Reactions to concentrated influenza virus vaccines. J Immunol 58, 369-395.
44. Sheffield, F. W., Smith,W. & Belyavin, G. (1954). Purification of influenza virus by red-cell adsorption and elution. Br J Exp Pathol 35, 214-222.
45. Szretter, K. J., Balish, A. L. & Katz, J. M. (2006). Influenza: propagation, quantification, and storage. Curr Protoc Microbiol Chapter 15, Unit 15G.1.
46. Takada, A., Kuboki, N., Okazaki, K., Ninomiya, A., Tanaka, H., Ozaki, H., Itamura, S., Nishimura, H., Enami, M. & other authors (1999). Avirulent avian influenza virus as a vaccine strain against a potential human pandemic. J Virol 73, 8303-8307.
47. Takada, A., Matsushita, S., Ninomiya, A., Kawaoka, Y. & Kida, H. (2003). Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice. Vaccine 21, 3212-3218. (Pubitemid 36700428)
48. Tumpey, T. M., Renshaw, M., Clements, J. D. & Katz, J. M. (2001). Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection. J Virol 75, 5141-5150. (Pubitemid 32448536)
49. WHO (2005). Immunization against diseases of public health importance. In Fact Sheets. No. 288, WHO.
50. Zheleznova, N. V. (1982). Method of influenza virus UV inactivation applied to the manufacture of an inactivated chromatographic influenza vaccine. Tr Inst Im Pastera 59, 81-88.